13F HOLDINGS REPORT
PATHWAY CAPITAL MANAGEMENT, LP
Quarter ended Q3 2025 · Filed November 4, 2025 · Accession 0001214659-25-015847
Total Value
$20.3M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HIMS & HERS HEALTH, INC. | HIMS | 119,279 | $6.8M | 33.26% |
| 2 | ARCELLX, INC. | ACLX | 51,051 | $4.2M | 20.60% |
| 3 | GOODRX HOLDINGS, INC. | GDRX | 986,158 | $4.2M | 20.51% |
| 4 | CRISPR THERAPEUTICS AG | CRSP | 50,049 | $3.2M | 15.95% |
| 5 | PDD HOLDINGS INC. | PDD | 7,197 | $951,227 | 4.68% |
| 6 | NU HOLDINGS LTD. | NU | 59,010 | $944,750 | 4.64% |
| 7 | NEUEHEALTH INC | 10920V404 | 11,201 | $74,711 | 0.37% |